PhD in Biologics Process Engineering

Program Overview

The PhD in Biologics Process Engineering is a 3-year, full-time program designed for industry professionals seeking a PhD without interrupting their careers. Delivered by the Jefferson Institute for Bioprocessing, the program focuses on developing research skills in process and product development for emerging therapies, particularly in cell and gene therapy and genomic vaccines. The program emphasizes automation, computational methodologies, and continuous bioprocessing, and fosters collaboration between life sciences, physics, mathematics, and engineering.

Program Outline

Degree Overview:

The PhD in Biologics Process Engineering is a full-time, 3-year program requiring a minimum of 54 credits to graduate. The program is designed to foster and provide real-life experience in process and product development, focusing on translating life science discoveries in emerging therapies into practical outcomes.

Objectives:

The program aims to promote the attainment of marked ability, scholarship, leadership, and research skills within the field of biologics process engineering.

Program Description:

The program focuses on addressing technical process and scale-up challenges associated with the commercialization of Advanced Therapy Medicinal Products (ATMPs), including cell and gene therapy, as well as genomic vaccines.

Other:

• The program is specifically designed for individuals seeking a PhD level research program but find it challenging to return from industry to pursue their degree.
• The program is open to individuals with a master's degree in a relevant area and a sponsoring company in the biopharma sector.
Privately funded options are also available.
• The program is delivered by the Jefferson Institute for Bioprocessing (JIB), which has a faculty and staff with extensive experience in the field.
• JIB's research focuses on addressing relevant scale-up issues and creating the necessary bioprocess engineering solutions for ATMPs.